Top Markets
#1 EXOD EXOD +56.80%
#2 MowCat MowCat +48.13%
#3 CoW Protocol CoW Protocol +37.72%
#4 Glidr Glidr +36.87%
#5 RedStone RedStone +30.25%
#6 Humanity Humanity +24.45%
#7 Codatta Codatta +21.34%
#8 The Black Bull The Black Bull +19.65%
#9 Walrus Walrus +19.14%
#10 Tutorial Tutorial +19.10%
Coin of the day
EXOD EXOD
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Accustem Sciences Inc. Accustem Sciences Inc.

Accustem Sciences Inc.

ACUT
Rangering i aksjer #36602
AccuStem Sciences, Inc. operates as a life science firm committed to improving... AccuStem Sciences, Inc. operates as a life science firm committed to improving the outlook for individuals battling cancer. Its primary innovation is the StemPrintER technology, an advanced multi-gene prognostic assay designed to predict the likelihood of recurrence for patients with Endocrine receptor-positive /HER2- breast cancer. The company also offers Spare, a related diagnostic tool that expands upon StemPrintER by incorporating two additional clinical markers. AccuStem Sciences, Inc. is based in New York, New York.
Aksjekurs
$0.156
Sist synkronisert: 2026-08-13
Markedsverdi
$2.51M
Endring (1 dag)
2.97%
Endring (1 år)
-91.28%
Land
US
Handel Accustem Sciences Inc. (ACUT)

Kategori

Healthcare
EPS for Accustem Sciences Inc. (ACUT)
EPS per 2026 TTM: 0
Ifølge de siste økonomiske rapportene og aksjekursen til Accustem Sciences Inc. er selskapets nåværende EPS (TTM) 0. Ved slutten av 2026 hadde selskapet en EPS på 0, lik EPS-en i 2026 som var 0.
EPS-historikk for Accustem Sciences Inc. fra 2026 til 2026
EPS ved slutten av hvert år
År EPS Endre
Ikke nok data for de angitte datoene.
EPS for lignende selskaper eller konkurrenter
Selskap EPS EPS-forskjell Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $13.70 -
BE